Liao Haiyan, Cai Songhua, Bai Yuezong, Zhang Bei, Sheng Yuling, Tong Shuang, Cai Jinping, Zhao Feilong, Zhao Xiaochen, Chen Shiqing, Zhang Cheng, Gao Jing
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen, China.
Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute Beijing, China.
Am J Cancer Res. 2021 Nov 15;11(11):5571-5580. eCollection 2021.
Colorectal cancer (CRC) is one of the most heritable cancers, and genetic factors play an important role in the increased CRC risk. However, the well-established CRC-risk genes were limited for explaining the increased risk of CRC individuals. Germline mutations in DNA damage repair (DDR) genes have also been reported to be implicated in CRC heritability. Here, we aimed to determine the prevalence and significance of germline DDR and well-established CRC-risk gene variants in CRCs with paired somatic analyses. Next-generation sequencing (NGS) was performed on tumor tissues and paired white blood cells collected from 2160 Chinese patients with CRC using well-designed 381- or 733-cancer gene panel. Germline/somatic variations were identified and assessed for pathogenicity and likely pathogenicity. Of 2160 CRCs, 136 pathogenic germline mutations in 133 patients (133/2160, 6.1%) were identified in 21 genes, including 19 out of 32 examined DDR genes. Compared with non-carriers, individuals with germline variants were prone to a higher level of microsatellite instability (MSI) and tumor mutational burden (TMB), and an earlier age of onset. Somatic sequencing identified second hits in 24/133 (18%) patients with germline variants. Among the mismatch repair (MMR) genes with germline mutations, the second hit significantly increased MSI and TMB, particularly apparent in . All MMR germline variation carriers further with a second hit were all MSI-H and had an extraordinarily high level of TMB. Collectively, approximately 6.1% of CRC patients carried pathogenic germline variants, and additional somatic second hit increases the genomic instability in CRC, whereas the more clinical significance warrants further study.
结直肠癌(CRC)是遗传性最强的癌症之一,遗传因素在CRC风险增加中起重要作用。然而,已明确的CRC风险基因在解释CRC个体风险增加方面存在局限性。据报道,DNA损伤修复(DDR)基因中的种系突变也与CRC遗传性有关。在此,我们旨在通过配对体细胞分析确定CRC中种系DDR和已明确的CRC风险基因变异的患病率及意义。使用精心设计的381个或733个癌症基因面板,对从2160例中国CRC患者收集的肿瘤组织和配对白细胞进行了下一代测序(NGS)。鉴定种系/体细胞变异并评估其致病性和可能的致病性。在2160例CRC中,在21个基因中鉴定出133例患者(133/2160,6.1%)的136个致病性种系突变,包括32个检测的DDR基因中的19个。与非携带者相比,有种系变异的个体更容易出现更高水平的微卫星不稳定性(MSI)和肿瘤突变负荷(TMB),且发病年龄更早。体细胞测序在24/133(18%)有种系变异的患者中发现了二次打击。在具有种系突变的错配修复(MMR)基因中,二次打击显著增加了MSI和TMB,在……中尤为明显。所有进一步发生二次打击的MMR种系变异携带者均为MSI-H,且TMB水平极高。总体而言,约6.1%的CRC患者携带致病性种系变异,额外的体细胞二次打击增加了CRC中的基因组不稳定,而更多的临床意义值得进一步研究。